The Department of Health and Human Services announced on July 29 that it is looking to restrict sales of a widely available substance commonly used as a pain reliever.
The substance 7-Hydroxymitragynine, commonly known as 7-OH, is a synthetic, concentrated form of kratom, a plant extract that is a stimulant at low doses, but has sedative effects when taken in high doses.
FDA Commissioner Dr. Marty Makary warned that “7-OH is an opioid that can be more potent than morphine.”
The FDA will take steps to add 7-OH to its list of “scheduled” drugs, categorizing it according to medicinal use and potential for addiction, Dr. Makary said at a press conference on Tuesday….